Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HYFTthis companyMindWalk Holdings Corp.	$1.10	-5.39×	6.39×	4.89×	-5.11×	-295.2%	58.8%	-96.0%	-89.7%	-117.1%	-89.2%	-16.9%	0.3×	0.59×	0×	2.8×	0.0%	3	-9.88	1	D+
ALXOALX Oncology Holdings Inc.	$1.18	-0.59×	2.33×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-391.4%	-262.0%	-139.1%	0.2×	0.11×	-64.93×	2.07×	0.0%	2	-2.66	2	C
ATYRaTyr Pharma, Inc.	$7.03	-0.98×	1.08×	383.2×	-1.02×	-128.4%	-717.4%	-40856.3%	-39009.5%	-109.8%	-96.5%	-85.2%	0.18×	-0.02×	0×	5.3×	0.0%	2	-14.23	2	C
BYSIBeyondSpring Inc.	$0.61	-8.15×	-2.05×	0×	-6.84×	-78.1%	0.0%	0.0%	0.0%	24.8%	-70.6%	-30.5%	-0.01×	0.87×	0×	1.54×	0.0%	1	-41.21	2	C+
CAMPCAMP4 Therapeutics Corporation	$4.49	-2.31×	3.9×	53.24×	-1.56×	-1164.1%	53.1%	-1488.3%	-2298.5%	-168.5%	-50.8%	-16.0%	0.04×	2.13×	0×	7.35×	0.0%	1	-5.32	2	C
CLNNClene Inc.	$4.84	-2.22×	-3.29×	289.36×	-3.38×	-148.3%	78.5%	-11541.5%	-13086.5%	148.8%	-188.6%	-32.1%	-1.23×	-0.75×	-8.61×	0.83×	0.0%	2	-23.05	2	C
Peer median	—	-2.22×	1.08×	53.24×	-1.56×	-128.4%	0.0%	-1488.3%	-2298.5%	-109.8%	-96.5%	-32.1%	0.04×	0.11×	0×	2.07×	0.0%	2	-14.23	2	—